Call for Abstracts - VPH Research to Business Session

Tuesday, 30 March 2010

For the second year, the VPH Network of Excellence is organising a two-day meeting where the VPH community showcases its best results to the biomedical industry. This is not only to increase the exploitation potential of VPH research, but also to expand the take-on of VPH technologies in the health industry.

This year the program revolves around three types of sessions:

• Research to Business (R2B), where research consortia present to industry delegates the best results they achieved;
• Business to Business (B2B), where small and large companies, as well as university spin-offs present products and services that other companies can use to develop other products and services for the final end-user.
• Regulatory to Business (G2B), where experts of regulatory affair will report on the position of simulation technologies with respect to regulatory affairs.

VPH research projects are invited to participate in this event in three ways:

• Ensuring that industrial partners of your consortia are informed of the event and are motivated to send delegates
• Explore with their industrial partners or spin-offs the interest to present their products and services at the B2B session. Those interested should contact Elena Villalba Mora, This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
• Submit an abstract of the presentation on the best research results they would like to showcase in the R2B session.

Selection Criteria
The draft programme consists of 12 slots of 30-minutes for each presentation. In the event that abstracts received are more than the number of available slots, the organisation of the event will make a selection according to the following criteria:

• Fair representation of all projects (if two abstracts come from the same project one might be excluded)
• Broadest possible coverage of the clinical and industrial domains
• Closeness of results to be presented to the industrial/clinical exploitation

Consortia and research groups who wish to present, should follow the instructions below.

Submission of Abstracts
Your abstract must reach the event organisers no later than the 23rd of April 2010. Selected contributions will be invited for presentation during the 8th and 9th of September 2010.

Instructions for Submission of Abstracts
Please send your abstract to Vanessa Diaz, This e-mail address is being protected from spambots. You need JavaScript enabled to view it Abstracts will be between 350 and 500 words long, without including the title and the authors. The format is free; feel free to include illustrations.

Abstract Contents
Abstracts should cover the following topics:

• Subject of research
• Clinical and/or industrial translation
• Clinical uptake
• Development of tools if any

Evaluation
The event organisers will evaluate all abstracts. Notification of acceptance will be provided the last week of April.

For further information, please visit:
http://www.vph-noe.eu

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

• Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
• Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
• Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
• Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
• Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
• Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Finally, by involving clinical and industrial stakeholders, VPH NoE also plans to lay a reliable ground to support sustainable interactions and collaboration between research and healthcare communities.